from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1954c/-

LFCtreatmentdescriptionclass of inhibitor

0.228

Amikacinug/mL Amikacintranslation

0.642

Cap5-10ug/mL Capreomycintranslation

0.729

Rox10-50 ug/mL Roxithromycintranslation

0.690

SM2-5 ug/mL Streptomycintranslation

0.702

Tet5-10 ug/mL Tetracyclinetranslation

0.628

Rif0.2-5ug/mL Rifampicintranscription

-0.136

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.517

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.441

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.763

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.844

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.318

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.412

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.993

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.256

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.567

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.987

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.767

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.386

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.135

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.830

KCN5-20 ug/mL Potassium cyaniderespiration

-0.420

NaN30.2-2 mM Sodium aziderespiration

0.349

Nigericin50 uM Nigericinrespiration

-0.171

TRC10-150 ug/mL Triclosanrespiration

-1.519

TRZ10-25 ug/mL Thioridazinerespiration

1.997

Valinomycin0.5-10 uM Valinomycinrespiration

0.420

ZnSO42 mM ZnSO4respiration

-0.043

menadione6-10 ug/mL Menadionerespiration

-0.883

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.026

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.394

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.204

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.788

NRP_1Non-replicating persistence stage 1dosRassociated

0.128

Amp0.2mg/mL AmpicillincellWall

-0.313

Cephalexin20-100 ug/mL CephalexincellWall

0.041

Cerulenin0.32-5 ug/mL CerulenincellWall

0.076

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.125

EMB10-20 ug/mL EthambutolcellWall

-0.324

Eta12-40 ug/mL EthionamidecellWall

-0.131

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.484

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.291

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.734

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.849

BZA0.12 mg/mL BenzamidearomaticAmides

-0.113

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.347

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.711

H2O24 mM hydrogen peroxideDNAdamaging

-0.116

Levo10 ug/mL LevofloxacinDNAdamaging

0.768

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.258

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.233

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.776

UVUV-irradiationDNAdamaging

-0.163

ARP41-4 ug/mL Antitubercular compound ARP4?

0.158

Antimycin12.5-50 ug/mL Antimycin A?

-0.770

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.626

PA_110-50 ug/mL Antitubercular compound PA-1?

0.034

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.734

PA8240.2-2 ug/mL PA-824?

-0.833

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.241

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.597

Verapamil50 uM Verapamil?

-0.407

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.671

methoxatin10-20 ug/mL Methoxatin?